Skip to main content
RBOT logo

RBOT

Vicarious Surgical Inc.
$0.17 +0.00 (+1.23%) At close · Jul 14
Market Cap
$1.18M
Shares
7,124,218

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.17 Open$0.17 Day$0.16–0.17 52W$0.14–13.75 Avg vol 30d70K Short int52K · 0.7% float · 1.0d Short vol14% Last earningsMar 9, 2026 DataSep 2020–Jul 2026 Filing10-Q · Apr 30
Up next
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Apr 30, 2026
Equibles Rating blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 16.5 · calm Equity put/call 0.62
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −92%
below
Price vs 50-day avg −66%
below
RSI (14) 32
neutral
MACD trend Positive
52-week position 0%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −68%
trailing
6-month return −94%
trailing
YTD return −92%
this year
Relative strength −105%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $0 › 200d $2 — 200d above 50d
Institutional flow Distributing
-78% holders QoQ · +1 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.73% of float · ▼ -12.3% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
8 holders — near 2-yr low, contrarian setup
Squeeze score 31
low risk · 0–100
Fundamentals
Weak
EPS growth −1325%
Y/Y
Free cash flow $-45.2M
Balance sheet $569.0K
net cash
Quant / Vol
risk profile
Very High
Volatility 184%
annualized · 1-yr
Max drawdown −99%
past year
ATR 32.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−92% Bearish
Price vs 50-day avg
−66% Bearish
RSI (14)
32 Neutral
MACD trend
Positive Bullish
52-week position
0% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $0 › 200d $2 — 200d above 50d
Institutional flow Distributing
-78% holders QoQ · +1 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.73% of float · ▼ -12.3% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
8 holders — near 2-yr low, contrarian setup
Price context
position in its 52-week range
52-wk low $0 Now $0 · 0% 52-wk high $14
vs 200-day avg -92% vs 50-day avg -66%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
RBOT
Vicarious Surgical Inc.
this stock
$1.18M -92.4% 0.7%
ABT
Abbott Laboratories
$154.95B -28.6% +5.7% 24.9 1.3%
SYK
Stryker Corp
$119.25B -11.3% +11.2% 36.0 1.8%
MDT
Medtronic plc
$101.51B -16.8% +8.4% 21.3 1.5%
BSX
Boston Scientific Corp
$63.36B -55.3% +5.5% 17.8 1.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
8
% held
1.3%
Net QoQ
-2.0M sh
Top holder
Aspex Management (HK) Ltd
Held Float
View
Held by Funds
Fund positions
4
View
Short & Settlement
Short Interest Falling
Shares short
52.3K
Days to cover
1.0d
Change
-7.3K sh
View
Short Volume
Short vol %
14%
As of
Jul 14, 2026
Short Total
View
Fails to Deliver
FTD shares
2
Value
$1
As of
Apr 16, 2026
View
Off-Exchange
Off-exchange %
100.0%
Week of
May 4, 2026
Off-exch Lit
View
Financials
Financials
Net income (FY)
$-50.2M
EPS diluted
$-14.70
View
Filings
SEC Filings
Latest
8-K
Filed
Jun 24, 2026
This year
11
View
Proposed Sales
Value
$530
Shares
276
Filed
Mar 3, 2026
View
Exempt Offerings
Offering
$11.7M
Filed
Oct 15, 2025
View
Earnings & Events
Earnings Calls
Last call
Mar 9, 2026
View
Investor Relations
Latest news
Vicarious Surgical Demonstrates S…
Published
May 13, 2026
View

Performance

5D 20D 120D MTD YTD
RBOT +4.4% -67.7% -93.6% +14.6% -92.4%
SPY +0.6% +1.4% +11.0% +0.7% +10.3%
vs SPY +3.9% -69.0% -104.5% +13.9% -102.7%
Key facts CIK 1812173 CUSIP 92561V208 Visit website Investor relations